Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Ruqi Tang is active.

Publication


Featured researches published by Ruqi Tang.


Gut | 2018

Gut microbial profile is altered in primary biliary cholangitis and partially restored after UDCA therapy

Ruqi Tang; Yiran Wei; Yanmei Li; Weihua Chen; Haoyan Chen; Qixia Wang; Fan Yang; Qi Miao; Xiao Xiao; Haiyan Zhang; Min Lian; Xiang Jiang; Jun Zhang; Qin Cao; Zhuping Fan; Maoying Wu; Jing-Yuan Fang; Aftab A. Ansari; M. Eric Gershwin; Xiong Ma

Objective A close relationship between gut microbiota and some chronic liver disorders has recently been described. Herein, we systematically performed a comparative analysis of the gut microbiome in primary biliary cholangitis (PBC) and healthy controls. Design We first conducted a cross-sectional study of 60 ursodeoxycholic acid (UDCA) treatment-naïve patients with PBC and 80 matched healthy controls. Second, an independent cohort composed of 19 treatment-naïve patients and 34 controls was used to validate the results. Finally, a prospective study was performed in a subgroup of 37 patients with PBC who underwent analysis before and after 6u2005months of UDCA treatment. Faecal samples were collected, and microbiomes were analysed by 16S ribosomal RNA gene sequencing. Results A significant reduction of within-individual microbial diversity was noted in PBC (p=0.03). A signature defined by decreased abundance of four genera and increased abundance of eight genera strongly correlated with PBC (area under curve=0.86, 0.84 in exploration and validation data, respectively). Notably, the abundance of six PBC-associated genera was reversed after 6u2005months of UDCA treatment. In particular, Faecalibacterium, enriched in controls, was further decreased in gp210-positive than gp210-negative patients (p=0.002). Of interest was the finding that the increased capacity for the inferred pathway, bacterial invasion of epithelial cells in PBC, highly correlated with the abundance of bacteria belonging to Enterobacteriaceae. Conclusions This study presents a comprehensive landscape of gut microbiota in PBC. Dysbiosis was found in the gut microbiome in PBC and partially relieved by UDCA. Our study suggests that gut microbiota is a potential therapeutic target and diagnostic biomarker for PBC.


Molecular Oncology | 2014

Long noncoding RNA profiles identify five distinct molecular subtypes of colorectal cancer with clinical relevance

Haoyan Chen; Jie Xu; Jie Hong; Ruqi Tang; Xi Zhang; Jing-Yuan Fang

Colorectal cancer (CRC) is a heterogeneous disease in terms of clinical behavior and response to therapy. Increasing evidence suggests that long noncoding RNAs (lncRNAs) are frequently aberrantly expressed in cancers, and some of them have been implicated in CRC biogenesis and prognosis. Using an lncRNA‐mining approach, we constructed lncRNAs expression profiles in approximately 888 CRC samples. By applying unsupervised consensus clustering to LncRNA expression profiles, we identified five distinct molecular subtypes of CRC with different biological pathways and phenotypically distinct in their clinical outcome in both univariate and multivariate analysis. The prognostic significance of the lncRNA‐based classifier was confirmed in independent patient cohorts. Further analysis revealed that most of the signature lncRNAs positively correlated with somatic copy number alterations (SCNAs). This lncRNAs‐based classification schema thus provides a molecular classification applicable to individual tumors that has implications to influence treatment decisions.


Clinical Reviews in Allergy & Immunology | 2015

Emperipolesis Mediated by CD8 T Cells Is a Characteristic Histopathologic Feature of Autoimmune Hepatitis

Qi Miao; Zhaolian Bian; Ruqi Tang; Haiyan Zhang; Qixia Wang; Shanshan Huang; Xiao Xiao; Li Shen; Edward L. Krawitt; M. Eric Gershwin; Xiong Ma

Emperipolesis has been widely described in patients with autoimmune hepatitis, but the significance and the diagnostic value have not been quantitated. The goal of this study was to define the features and clinical significance of emperipolesis in autoimmune hepatitis (AIH). A retrospective histological evaluation of 101 patients with AIH and 184 controls was performed. Confocal staining for CD4, CD8, CD19, CD56, CD163, and CD11b, CK8/18 and cleaved caspase-3 was performed. Emperipolesis was observed in 65.3xa0% of the patients with AIH in haematoxylin and eosin (H&E)-stained slides, which was significantly higher than in patients with primary biliary cirrhosis (17.9xa0%), chronic hepatitis B (14.9xa0%), and drug-induced liver injury (25.6xa0%). Among AIH patients, the patients with emperipolesis had significantly higher serum (alanine aminotransferase/aspartate aminotransferase [ALT/AST]) levels. Histologically, emperipolesis was associated with more severe necroinflammatory features and more advanced fibrosis. The lymphocytes in hepatocytes were predominantly as CD8 T cells. Emperipolesis of CD8 T cells induced cleaved caspase-3 expression, and was prominent in areas apoptosis. Emperipolesis is a characteristic feature of AIH which is often seen in conjunction with interface hepatitis, plasmacytic infiltration and hepatocyte rosetting and is associated with more severe necroinflammatory and fibrotic changes. In AIH, emperipolesis is predominantly mediated by CD8 T cells, appears to induce apoptosis and may be another mechanism of autoimmune-mediated hepatocyte injury.


Clinical Reviews in Allergy & Immunology | 2015

Multiple Genetic Variants Associated with Primary Biliary Cirrhosis in a Han Chinese Population

Ming Dong; Jinxin Li; Ruqi Tang; Ping Zhu; Fang Qiu; Chan Wang; Jie Qiu; Lan Wang; Yaping Dai; Ping Xu; Yueqiu Gao; Chongxu Han; Yongzhong Wang; Jian Wu; Xudong Wu; Kui Zhang; Na Dai; Weihao Sun; Jianpo Zhou; Zhigang Hu; Lei Liu; Yuzhang Jiang; Jinshan Nie; Yi Zhao; Yuhua Gong; Ye Tian; Hualiang Ji; Zhijun Jiao; Po Jiang; Xingjuan Shi

Multiple genome-wide association studies of primary biliary cirrhosis (PBC) in both European and Japanese ancestries have shown significant associations of many genetic loci contributing to the susceptibility to PBC. Major differences in susceptibility loci between these two population groups were observed. In this study, we examined whether the most significant loci observed in either European and/or Japanese cohorts are associated with PBC in a Han Chinese population. In 1070 PBC patients and 1198 controls, we observed highly significant associations at CD80 (rs2293370, Pu2009=u20092.67u2009×u200910−8) and TNFSF15 (rs4979462, Pu2009=u20093.86u2009×u200910−8) and significant associations at 17q12-21 (rs9303277), PDGFB (rs715505), NF-κB1 (rs7665090), IL12RB2 (rs11209050), and STAT4 (rs7574865; all corrected P values <0.01). However, no association was observed for POU2AF1 (rs4938534), IL12A (rs485499 and rs2366408), IL7R (rs6897932), CXCR5 (rs715412), SOCS1 (rs725613), and TNFRSF1A (rs1800693). STAT4 (rs7574865) was strongly associated after additional control samples were analyzed. Our study is the first large-scale genetic analysis in a Han Chinese PBC cohort. These results do not only reflect that Han Chinese PBC patients share common genetic susceptibility genes with both their Japanese and European counterparts but also suggest a distinctly different genetic susceptibility profile.


Clinical Reviews in Allergy & Immunology | 2016

The Natural History and Prognosis of Primary Biliary Cirrhosis with Clinical Features of Autoimmune Hepatitis

Fan Yang; Qixia Wang; Zhaoyue Wang; Qi Miao; Xiao Xiao; Ruqi Tang; Xiaoyu Chen; Zhaolian Bian; Haiyan Zhang; Yue Yang; Li Sheng; Jing-Yuan Fang; Edward L. Krawitt; M. Eric Gershwin; Xiong Ma

Although a variant of primary biliary cirrhosis (PBC) characterized by features of autoimmune hepatitis (AIH) has been recognized for many years, few studies with ample numbers of patients have focused on its natural history. This study aimed to clarify the natural history, prognosis, and response to therapy in a cohort of patients with PBC with AIH features. We retrospectively analyzed 277 PBC patients without AIH features and 46 PBC patients with AIH features seen between September 2004 and April 2014. The 5-year adverse outcome-free survival of PBC patients with AIH features was 58xa0% compared to 81xa0% in PBC patients without AIH features. Multivariate analysis in the patients with AIH features indicated that total bilirubin ≥2.70× the upper limit of normal predicted a poor prognosis (pu2009=u20090.008, relative risk 8.39, 95% confidence interval (CI) 1.73, 40.73). Combination therapy with ursodeoxycholic acid (UDCA) and immunosuppression provided better short-term responses in PBC patients with AIH features, defined by multiple criteria. Higher aspartate aminotransferase (AST) level at accession suggested better prognosis for PBC patients with AIH features while worse prognosis for PBC patients without AIH features. PBC patients with AIH features differ from those without AIH features in terms of natural history, prognostic indicators, and response to therapy.


Human Genetics | 2008

Positive association between OLIG2 and schizophrenia in the Chinese Han population

Ke Huang; Wei Tang; Ruqi Tang; Zhao Xu; Zhangdong He; Zhiqiang Li; Yifeng Xu; Xingwang Li; Guang He; Guoying Feng; Lin He; Yongyong Shi

A recent study reported that OLIG2 had a significant association with schizophrenia in the UK population. We genotyped three variants scattered among the genomic region of OLIG2, namely rs1005573, rs762178 and rs1059004 in a sample consisting of 329 schizophrenia patients and 288 controls. The results provide further evidence that the SNP rs762178 in OLIG2 seems to be a potential candidate in altering risk for schizophrenia in the Chinese Han population and worthy of further replication and functional study.


Autoimmunity Reviews | 2017

Bile acids and intestinal microbiota in autoimmune cholestatic liver diseases

You Li; Ruqi Tang; Patrick S.C. Leung; M. Eric Gershwin; Xiong Ma

Autoimmune cholestatic liver diseases, including primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC), are manifested as an impairment of normal bile flow and excessive accumulation of potentially toxic bile acids. Endogenous bile acids are involved in the pathogenesis and progression of cholestasis. Consequently, chronic cholestasis affects the expression of bile acid transporters and nuclear receptors, and results in liver injury. Several lines of evidence suggest that intestinal microbiota plays an important role in the etiopathogenesis of cholestatic liver diseases by regulating metabolism and immune responses. However, progression of the disease may also affect the composition of gut microbiota, which in turn exacerbates the progression of cholestasis. In addition, the interaction between intestinal microbiota and bile acids is not unidirectional. Bile acids can shape the gut microbiota community, and in turn, intestinal microbes are able to alter bile acid pool. In general, gut microbiota actively communicates with bile acids, and together play an important role in the pathogenesis of PBC and PSC. Targeting the link between bile acids and intestinal microbiota offers exciting new perspectives for the treatment of those cholestatic liver diseases. This review highlights current understanding of the interactions between bile acids and intestinal microbiota and their roles in autoimmune cholestatic liver diseases. Further, we postulate a bile acids-intestinal microbiota-cholestasis triangle in the pathogenesis of autoimmune cholestatic liver diseases and potential therapeutic strategies by targeting this triangle.


Alimentary Pharmacology & Therapeutics | 2017

The risk predictive values of UK-PBC and GLOBE scoring system in Chinese patients with primary biliary cholangitis: the additional effect of anti-gp210

Fan Yang; Yue Yang; Qixia Wang; Zhaohui Wang; Qi Miao; Xiao Xiao; Yiran Wei; Z. Bian; Li Sheng; Xiaoyu Chen; Jianhua Fang; Ruqi Tang; M. E. Gershwin; Xiong Ma

Adequate risk stratification is critical for the management of the patients with primary biliary cholangitis (PBC). The UK‐PBC and GLOBE scoring systems for prognosis of PBC have been proposed recently, but have not been validated in Asian population.


Genes and Immunity | 2015

The cumulative effects of known susceptibility variants to predict primary biliary cirrhosis risk

Ruqi Tang; Haoyan Chen; Qi Miao; Zhaolian Bian; W. Ma; X. Feng; Michael F. Seldin; Pietro Invernizzi; M. E. Gershwin; Wilson Liao; Xiong Ma

Multiple genetic variants influence the risk for development of primary biliary cirrhosis (PBC). To explore the cumulative effects of known susceptibility loci on risk, we utilized a weighted genetic risk score (wGRS) to evaluate whether genetic information can predict susceptibility. The wGRS was created using 26 known susceptibility loci and investigated in 1840 UK PBC and 5164 controls. Our data indicate that the wGRS was significantly different between PBC and controls (P=1.61E−142). Moreover, we assessed predictive performance of wGRS on disease status by calculating the area under the receiver operator characteristic curve. The area under curve for the purely genetic model was 0.72 and for gender plus genetic model was 0.82, with confidence limits substantially above random predictions. The risk of PBC using logistic regression was estimated after dividing individuals into quartiles. Individuals in the highest disclosed risk group demonstrated a substantially increased risk for PBC compared with the lowest risk group (odds ratio: 9.3, P=1.91E−084). Finally, we validated our findings in an analysis of an Italian PBC cohort. Our data suggested that the wGRS, utilizing genetic variants, was significantly associated with increased risk for PBC with consistent discriminant ability. Our study is a first step toward risk prediction for PBC.


Progress in Neuro-psychopharmacology & Biological Psychiatry | 2008

No genetic association between NCAM1 gene polymorphisms and schizophrenia in the Chinese population

Zhao Xu; Zangdong He; Ke Huang; Wei Tang; Zhiqiang Li; Ruqi Tang; Yifeng Xu; Guoyin Feng; Lin He; Yongyong Shi

BACKGROUNDnThe neural cell adhesion molecule 1(NCAM1, aliases NCAM and CD56) is a cell-surface molecule which makes homophilic adhesion between neural cells involved in cell migration, axon outgrowth and synaptic plasticity. Recent studies reported that NCAM1 might act as a candidate schizophrenia susceptibility gene.nnnMETHODnWe genotyped five SNPs (rs1943620, rs1836796, rs1821693, rs686050, rs584427) within the NCAM1 gene and conducted a case-control study in 288 schizophrenic patients and 288 healthy subjects in the Chinese Han population. We compared allele and genotype frequencies and haplotype distributions between cases and controls.nnnRESULTnNo significant differences in allele and genotype frequencies were found for each single SNP between schizophrenic patients and healthy subjects. Moreover, there were no significant differences in haplotype distributions between cases and controls (global chi2=1.318, P=0.725, df=3).nnnCONCLUSIONnOur study suggests that the five SNPs within NCAM1 gene we studied may not play a major role in the schizophrenia susceptibility in the Chinese Han population.

Collaboration


Dive into the Ruqi Tang's collaboration.

Top Co-Authors

Avatar

Xiong Ma

Shanghai Jiao Tong University

View shared research outputs
Top Co-Authors

Avatar

Qi Miao

Shanghai Jiao Tong University

View shared research outputs
Top Co-Authors

Avatar

Qixia Wang

Shanghai Jiao Tong University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jing-Yuan Fang

Shanghai Jiao Tong University

View shared research outputs
Top Co-Authors

Avatar

Zhaolian Bian

Shanghai Jiao Tong University

View shared research outputs
Top Co-Authors

Avatar

Haiyan Zhang

Shanghai Jiao Tong University

View shared research outputs
Top Co-Authors

Avatar

Min Lian

Shanghai Jiao Tong University

View shared research outputs
Top Co-Authors

Avatar

Xiao Xiao

Shanghai Jiao Tong University

View shared research outputs
Top Co-Authors

Avatar

Yiran Wei

Shanghai Jiao Tong University

View shared research outputs
Researchain Logo
Decentralizing Knowledge